Home > Cardiology > ACC/WCC 2020 > ACC.20/WCC Highlights Podcast Part 1 of 3

ACC.20/WCC Highlights Podcast Part 1 of 3

Presented By
Dr Rachel Giles, Medicom
Conference
ACC 2020
Trial
VICTORIA trial, VOYAGER-PAD trial, TAILOR-PCI trial, PARTNER 3 trial, CARAVAGGIO trial
Order of abstracts: Armstrong et al - VICTORIA trial - Vericiguat shows beneficial effects in very high-risk HF population Bonaca et al - VOYAGER-PAD trial - Rivaroxaban and aspirin effective and safe for PAD patients Pereira et al - TAILOR-PCI trial - TAILOR-PCI misses endpoint but still provides valuable insights Leon et al - PARTNER 3 trial - 2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis Agnelli et al - CARAVAGGIO trial - Apixaban offers new perspective for cancer patients in need of anticoagulation Samama et al - Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on